TY - JOUR T1 - Defective Intracellular Calcium Handling in Monocrotaline-Induced Right Ventricular Hypertrophy: Protective Effect of Long-Term Endothelin-A Receptor Blockade with 2-Benzo[1,3]dioxol-5-yl-3-benzyl-4-(4-methoxy-phenyl-)- 4-oxobut-2-enoate-sodium (PD 155080) JF - Journal of Pharmacology and Experimental Therapeutics JO - J Pharmacol Exp Ther SP - 442 LP - 449 DO - 10.1124/jpet.300.2.442 VL - 300 IS - 2 AU - Friedrich Brunner AU - Gerald Wölkart AU - Stephen Haleen Y1 - 2002/02/01 UR - http://jpet.aspetjournals.org/content/300/2/442.abstract N2 - We studied the effect of long-term treatment with the oral endothelin (ET) ETA antagonist 2-benzo[1,3]dioxol-5-yl-3-benzyl-4-(4-methoxy-phenyl-)-4-oxobut-2-enoate-sodium (PD 155080; PD) on right ventricular intracellular calcium (Ca2+i) handling and cardiac and pulmonary artery function in control rats and rats with monocrotaline (MCT)-induced right-heart hypertrophy. Rats were given an intraperitoneal injection of either saline (controls;n = 9) or MCT (50 mg/kg; n = 12), resulting in pulmonary hypertension-induced myocardial hypertrophy, or MCT followed by the daily administration of PD (50 mg/kg) for 9 weeks (n = 9). After 9 weeks, right ventricular pressure was measured, and the hearts were removed and perfused in vitro. Right ventricular function and Ca2+i transients were recorded simultaneously on a beat-to-beat basis using aequorin. Surviving animals in the MCT group (58%) developed significant hypertrophy and had 2-fold higher right ventricular pressure and a prolonged duration of isovolumic contraction that correlated with a similar prolongation of the Ca2+i transient, indicating a reduced rate of Ca2+ sequestration in hypertrophy (P< 0.05 versus control). In the PD group, all animals survived, and right ventricular pressure, diastolic relaxation, Ca2+transport kinetics, and peak systolic and end-diastolic wall stress were all normalized (P > 0.05 versus control); and pulmonary artery endothelial function was partly restored (P < 0.05 versus MCT and control groups). These results demonstrate for the first time that long-term ETAreceptor antagonism normalizes myocardial cytosolic Ca2+modulation, which may contribute to the antihypertrophic and cardioprotective effect of ETA receptor therapy in this model. The American Society for Pharmacology and Experimental Therapeutics ER -